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The diagnosis of polycystic ovary syndrome (PCOS) in
adolescents is difficult as the pathological criteria used in
adults like menstrual irregularities, acne, hirsutism and
polycystic ovarian morphology could be normal physiolo-
gical findings during puberty; in addition the syndrome is
heterogeneous and there is limited high quality evidence.
[1-3] Three international conferences have been held
reporting different criteria for diagnosis of PCOS in
women [Table 1]. [4-6] The 2011 Australian PCOS
evidence-based guideline [1], the 2012 international
evidence-based workshop [2] and the 2013 Endocrine
Society Clinical Practice Guideline [3] highlight the issues
of applying adult criteria to diagnose PCOS in adolescents.
All criteria require exclusion of other conditions: non-
classic congenital adrenal hyperplasia, hypothyroidism,
Cushing syndrome, hyperprolactinemia or androgen produ-
cing tumours which can cause a PCOS-like picture.
Although diagnosis of PCOS is based on its reproductive
manifestations, it is a metabolic disorder. PCOS adoles-
cents are at a high risk of having or developing glucose tol-
erance abnormalities, dyslipidemia and hypertension.
Insulin resistance and the consequent development of
hyperinsulinaemia seem to be the central pathophysiologi-
cal mechanism that links PCOS to its associated metabolic
derangements; this can occur independent of weight sta-
tus. Obesity, which is commonly associated with PCOS,
exaggerates insulin abnormalities. Adolescents with PCOS
should have evaluation of glucose homeostasis and insulin
resistance at diagnosis.
PCOS management should include a multidisciplinary
team and should be individualized depending on the pre-
dominant complaint and weight status. Lifestyle modifica-
tions should be the first line treatment in the presence of
overweight, obesity and/or insulin resistance. Metformin
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Table 1 Diagnostic criteria for PCOS in women
PCOS
definition
Clinical (modified Ferriman-Gallway score >8*) or
biochemical hyperandrogenemia (elevated total or free
testosterone level **)
Oligomenorrhoea (< 6-9
menstrual cycles per year) or
oligo-anovulation
Polycystic ovaries on ultrasound (>12











1 of 2 criteria
* Ethnicity should be considered when assessing hirsutism
**Testosterone assays, puberty and time of the sample should be considered when reviewing levels.
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can also be added. Cyclical progesterone withdrawn bleed
or cyclical oral contraceptive pills are used for menstrual
irregularities. Antiandrogens like spironolactone and oral
contraceptive pills are used for hirsutism. Permanent treat-
ment with laser or electrolysis is usually advised after a
course of antiandrogens.
Various aspects of adolescent PCOS will be discussed
based on illustrative cases.
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